Litcius/Paper detail

Immunotherapy in ovarian cancer: we are not there yet

Emma L. Barber, Daniela Matei

2021The Lancet Oncology26 citationsDOIOpen Access PDF

Topics & Concepts

PembrolizumabMedicineAtezolizumabOncologyInternal medicineOvarian cancerLung cancerAvelumabCancerChemotherapyImmunotherapyCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapyBladder and Urothelial Cancer Treatments
Immunotherapy in ovarian cancer: we are not there yet | Litcius